• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    ReportInfographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    India Blood Grouping Reagents Market

    ID: MRFR/HC/51495-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    India Blood Grouping Reagents Market Research Report By Product (Consumables, Instruments), By Technique (PCR-based and Microarray Techniques, Assay-Based Techniques, Massively Parallel Sequencing Techniques, Serology), By Test Type (Blood Group and Phenotypes, Antibody Screening, Crossmatching Tests, Antibody Identification, Coombs’s Test, Antigen Typing) and By End User (Hospitals, Blood Banks, Clinical Laboratories)-Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    India Blood Grouping Reagents Market Research Report-Forecast to 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Table of Contents

    India Blood Grouping Reagents Market Summary

    The India Blood Grouping Reagents market is projected to grow significantly from 450 USD Million in 2024 to 1050 USD Million by 2035.

    Key Market Trends & Highlights

    India Blood Grouping Reagents Key Trends and Highlights

    • The market is expected to expand at a compound annual growth rate of 8.01 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 1050 USD Million, indicating robust growth potential.
    • In 2024, the market is valued at 450 USD Million, reflecting a solid foundation for future expansion.
    • Growing adoption of advanced diagnostic technologies due to increasing healthcare awareness is a major market driver.

    Market Size & Forecast

    2024 Market Size 450 (USD Million)
    2035 Market Size 1050 (USD Million)
    CAGR (2025 - 2035) 8.01%

    Major Players

    Reliance Industries Limited (IN), Tata Consultancy Services (IN), HDFC Bank Limited (IN), Infosys Limited (IN), ICICI Bank Limited (IN), State Bank of India (IN), Bharti Airtel Limited (IN), Hindustan Unilever Limited (IN), Wipro Limited (IN), Larsen & Toubro Limited (IN)

    India Blood Grouping Reagents Market Trends

    The India Blood Grouping Reagents Market is experiencing significant growth driven by various key market drivers. Increasing awareness regarding the importance of blood typing in transfusion medicine is leading to higher demand for reliable reagents. The rising prevalence of transfusion-related complications and the push for safe blood transfusions in healthcare facilities are also crucial factors fostering market expansion. Moreover, advancements in technology and the introduction of automated blood grouping systems have enhanced the efficiency and accuracy of blood testing.

    There are numerous opportunities to be explored in the Indian market.To further improve the healthcare infrastructure of India, the government has started programs that include upgrading blood banks and laboratories, thereby creating a market for quality blood grouping reagents. Partnerships between the public and private sectors will result in the development of products specifically designed for the Indian population. Furthermore, the economic development of the country will open up new opportunities in tailored medicine, which might increase the demand for certain blood grouping reagents. Recent blood grouping trends also show an increase in acceptance of advanced techniques like molecular typing.

    This shift is particularly relevant in urban areas where advanced healthcare services are becoming more accessible. The integration of digital technologies for data management in blood banks is also emerging as a trend, streamlining processes and enhancing traceability. The focus on minimizing human error and improving safety standards in blood transfusions highlights the necessity for quality reagents, as healthcare professionals prioritize patient safety and compliance with regulatory guidelines. These trends reflect a dynamic landscape in the India Blood Grouping Reagents Market, which is aligning itself with global advancements while catering to local needs.

    Source: Primary Research, Secondary Research, Market Research Future Database, and Analyst Review

    India Blood Grouping Reagents Market Drivers

    Market Segment Insights

    Blood Grouping Reagents Market Product Insights

    Blood Grouping Reagents Market Product Insights

    The India Blood Grouping Reagents Market is characterized by a diverse range of products, primarily categorized into Consumables and Instruments. Consumables play a crucial role in the operation of blood grouping, as they encompass various reagents and kits necessary for diagnosing and testing blood types. These materials are essential for laboratories and healthcare facilities, given the increasing number of blood transfusions and the rising prevalence of blood-related disorders in the country. The demand for Consumables has been supported by government initiatives focusing on improving blood safety protocols and enhancing healthcare infrastructure.

    Instruments, on the other hand, are instrumental in automating and streamlining the blood grouping process. These include various technologically advanced equipment that ensures accurate results and efficiency in testing. The integration of sophisticated analytical instruments is driving improvements in laboratory operations, making it essential for healthcare providers aiming to deliver timely and reliable blood typing services.

    Moreover, the burgeoning emphasis on Research and Development is propelling innovations in Instruments, which cater to a growing need for precision and speed in blood grouping tests.The landscape of the India Blood Grouping Reagents Market is shaped by growing healthcare expenditures, increased awareness about blood transfusion safety, and the rising incidence of blood disorders, all of which underscore the pivotal importance of both Consumables and Instruments. The differentiation in these categories reflects a robust framework aimed at enhancing diagnostic accuracy while catering to patient safety.

    As the market evolves, both segments are poised for growth, supported by the heightened focus on modernization and efficiency in healthcare service delivery. The overall market is experiencing a paradigm shift with technological advancements that are setting new benchmarks in the quality and reliability of blood grouping reagents, thereby enhancing the operational capabilities of laboratories across India.

    Blood Grouping Reagents Market Technique Insights

    Blood Grouping Reagents Market Technique Insights

    The India Blood Grouping Reagents Market, particularly within the Technique segment, exhibits significant growth potential driven by advancements in diagnostic technologies and increasing healthcare needs. As hospitals and diagnostic labs seek efficient and accurate blood grouping, techniques such as PCR-based and Microarray Techniques are gaining traction due to their ability to deliver rapid and precise results. These methods are vital in ensuring safe blood transfusions and organ transplants, thereby enhancing patient care.

    Assay-Based Techniques remain critical due to their effectiveness in determining blood types and compatibility, which is fundamental for transfusion medicine.Furthermore, Massively Parallel Sequencing Techniques offer a cutting-edge approach to genotyping, enabling comprehensive analysis of genetic variants in blood groups. Serology, being a traditional yet continually relevant method, plays an essential role in identifying blood groups and detecting antibodies. The rising incidence of blood-related disorders and the increasing emphasis on transfusion safety are expected to boost the adoption of these techniques within India’s healthcare infrastructure.

    Overall, the segmentation presents opportunities for innovation and growth, highlighting the importance of advanced methodologies in the India Blood Grouping Reagents Market.

    Blood Grouping Reagents Market Test Type Insights

    Blood Grouping Reagents Market Test Type Insights

    The Test Type segment of the India Blood Grouping Reagents Market plays a crucial role in ensuring the safety and effectiveness of blood transfusions and organ transplants. This segment includes various types of procedures, such as Blood Group and Phenotypes testing, which are essential for determining the compatibility between donors and recipients. Antibody Screening is critical in identifying unexpected antibodies that could lead to transfusion reactions. Additionally, Crossmatching Tests are vital in confirming donor-recipient compatibility, thereby preventing adverse reactions during transfusions.Antibody Identification processes contribute to a better understanding of the patient’s sensitization history, enhancing transfusion safety.

    Coombs’s Test is significant in diagnosing hemolytic anemias and ensuring safe blood products are administered. Finally, Antigen Typing assists in establishing blood types in a comprehensive approach to transfusion medicine. The growth of this segment is supported by increasing healthcare accessibility in India, government initiatives to improve healthcare systems, and rising awareness regarding blood safety.Consequently, technological advancements in testing methods and the increasing incidence of blood-related disorders contribute to the segment's importance in the overall India Blood Grouping Reagents Market.

    Blood Grouping Reagents Market End User Insights

    Blood Grouping Reagents Market End User Insights

    The End User segment within the India Blood Grouping Reagents Market plays a crucial role in the healthcare ecosystem, with various entities such as Hospitals, Blood Banks, and Clinical Laboratories driving significant demand. Hospitals are major users due to the increasing number of surgeries and emergency care procedures, which require precise blood typing for safe transfusions. Blood Banks, essential for maintaining an adequate supply of safe blood, focus on testing and quality assurance of blood products, thus directly impacting public health management.Clinical Laboratories cater to a growing patient base needing diagnostic testing, creating a surge in laboratory operations.

    The importance of this segment is underscored by a rising prevalence of blood-related disorders and accidents necessitating efficient blood grouping processes. Moreover, advancements in technology and increasing investments in healthcare infrastructure further fuel the growth within this segment. Thus, the End User segment is critical for enhancing healthcare delivery and ensuring patient safety in India. The evolving landscape of regulations and guidelines also contributes to the overall dynamics of the End User market, reinforcing its significance in the India Blood Grouping Reagents Market.

    Get more detailed insights about India Blood Grouping Reagents Market Research Report-Forecast to 2035

    Request Free Sample

    Regional Insights

    Key Players and Competitive Insights

    The India Blood Grouping Reagents Market has been witnessing significant development due to an increased emphasis on blood safety and the rising prevalence of blood disorders. The competitive landscape in this market is characterized by several key players striving to capture market share through innovative product offerings and strong distribution networks. Companies are focusing on enhancing their technological capabilities, compliance with regulatory standards, and expanding their footprint in the healthcare sector to cater to the increasing demand for accurate and efficient blood grouping solutions.

    As the population's awareness of health and safety measures grows, the competition among these firms intensifies, leading to strategies aimed at product differentiation, pricing, and customer service excellence.Siemens Healthineers has established a robust presence in the India Blood Grouping Reagents Market by leveraging its advanced technological capabilities and extensive experience in the diagnostic sector. The company is known for its state-of-the-art blood grouping reagents that deliver high accuracy and efficiency, appealing to hospitals and clinical laboratories across the country.

    Furthermore, Siemens Healthineers has strategically positioned itself to offer comprehensive solutions that not only meet the regulatory demands but also cater to the evolving needs of healthcare providers. Their strong brand reputation and commitment to high-quality manufacturing enhance their competitive edge, while their investments in research and development ensure continuous innovation tailored for the Indian market.F. Hoffmann-La Roche also plays a vital role in the India Blood Grouping Reagents Market, where it focuses on providing a diverse array of diagnostic solutions, including high-quality blood grouping reagents.

    The company's portfolio includes advanced products designed for precise blood typing and compatibility testing, thereby reinforcing safety in blood transfusions. Roche's strong market presence is bolstered by its commitment to quality, reliability, and ongoing investment in regional partnerships and distributor networks throughout India. Additionally, the company has engaged in strategic mergers and acquisitions to enhance its capabilities and expand its product offerings in the Indian healthcare landscape.

    Roche's strengths lie in its established reputation for innovation and commitment to improving healthcare outcomes, which resonate strongly within the Indian market, enabling it to cater effectively to the growing demand for blood grouping reagents.

    Key Companies in the India Blood Grouping Reagents Market market include

    Industry Developments

    Market Segmentation

    Outlook

    • Hospitals
    • Blood Banks
    • Clinical Laboratories

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2023 0.01(USD Million)
    MARKET SIZE 2024 0.05(USD Million)
    MARKET SIZE 2035 0.36(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 18.972% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Siemens Healthineers, F. HoffmannLa Roche, Randox Laboratories, Abbott Laboratories, Werfen, BioRad Laboratories, Hematologic Technologies, Ortho Clinical Diagnostics, DiaSorin, Thermo Fisher Scientific, Progenika Biopharma, Grifols, Merck KGaA, SeraCare Life Sciences, Becton Dickinson
    SEGMENTS COVERED Product, Technique, Test Type, End User
    KEY MARKET OPPORTUNITIES Rising demand for accurate diagnostics, Growing awareness of blood safety, Expansion of healthcare infrastructure, Advancements in technology and automation, Increasing prevalence of blood disorders
    KEY MARKET DYNAMICS increasing healthcare awareness, rising demand for blood transfusions, technological advancements in diagnostics, government initiatives for blood safety, growing prevalence of blood disorders
    COUNTRIES COVERED India

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Get In Touch
    Leave a Comment

    FAQs

    What is the expected market size of the India Blood Grouping Reagents Market in 2024?

    The India Blood Grouping Reagents Market is expected to be valued at 0.05 USD Million in 2024.

    How much is the India Blood Grouping Reagents Market projected to grow by 2035?

    By 2035, the market is projected to grow to 0.36 USD Million.

    What is the expected compound annual growth rate (CAGR) for the market during the forecast period?

    The expected CAGR for the India Blood Grouping Reagents Market is 18.972% from 2025 to 2035.

    Which product sub-segment is leading the India Blood Grouping Reagents Market?

    The consumables sub-segment is expected to lead the market, valued at 0.03 USD Million in 2024 and 0.25 USD Million in 2035.

    What is the market size projection for the instruments sub-segment by 2035?

    The instruments sub-segment is projected to reach 0.11 USD Million by 2035.

    Who are the major players in the India Blood Grouping Reagents Market?

    Key players include Siemens Healthineers, F. HoffmannLa Roche, and Abbott Laboratories among others.

    What are the growth drivers for the India Blood Grouping Reagents Market?

    The growth drivers include rising healthcare needs, advancements in diagnostic technology, and increasing blood donation awareness.

    How are current global scenarios affecting the India Blood Grouping Reagents Market?

    Current global scenarios can influence raw material availability and price fluctuations, impacting market dynamics.

    Is there a specific region in India where the Blood Grouping Reagents Market is expected to grow significantly?

    Certain urban and metropolitan areas are expected to show significant growth due to better healthcare facilities.

    What are the emerging trends in the India Blood Grouping Reagents Market?

    Emerging trends include the adoption of automation, enhanced product innovation, and integration of digital technologies in diagnostics.

    1. EXECUTIVE SUMMARY
    2. Market Overview
    3. Key Findings
    4. Market Segmentation
    5. Competitive Landscape
    6. Challenges and Opportunities
    7. Future Outlook
    8. MARKET INTRODUCTION
    9. Definition
    10. Scope of the study
    11. Research Objective
    12. Assumption
    13. Limitations
    14. RESEARCH METHODOLOGY
    15. Overview
    16. Data Mining
    17. Secondary Research
    18. Primary Research
    19. Primary Interviews and Information Gathering Process
    20. Breakdown of Primary Respondents
    21. Forecasting Model
    22. Market Size Estimation
    23. Bottom-Up Approach
    24. Top-Down Approach
    25. Data Triangulation
    26. Validation
    27. MARKET DYNAMICS
    28. Overview
    29. Drivers
    30. Restraints
    31. Opportunities
    32. MARKET FACTOR ANALYSIS
    33. Value chain Analysis
    34. Porter's Five Forces Analysis
    35. Bargaining Power of Suppliers
    36. Bargaining Power of Buyers
    37. Threat of New Entrants
    38. Threat of Substitutes
    39. Intensity of Rivalry
    40. COVID-19 Impact Analysis
    41. Market Impact Analysis
    42. Regional Impact
    43. Opportunity and Threat Analysis
    44. India Blood Grouping Reagents Market, BY Product (USD Million)
    45. Consumables
    46. Instruments
    47. India Blood Grouping Reagents Market, BY Technique (USD Million)
    48. PCR-based and Microarray Techniques
    49. Assay-Based Techniques
    50. Massively Parallel Sequencing Techniques
    51. Serology
    52. India Blood Grouping Reagents Market, BY Test Type (USD Million)
    53. Blood Group and Phenotypes
    54. Antibody Screening
    55. Crossmatching Tests
    56. Antibody Identification
    57. Coombs’s Test
    58. Antigen Typing
    59. India Blood Grouping Reagents Market, BY End User (USD Million)
    60. Hospitals
    61. Blood Banks
    62. Clinical Laboratories
    63. Competitive Landscape
    64. Overview
    65. Competitive Analysis
    66. Market share Analysis
    67. Major Growth Strategy in the Blood Grouping Reagents Market
    68. Competitive Benchmarking
    69. Leading Players in Terms of Number of Developments in the Blood Grouping Reagents Market
    70. Key developments and growth strategies
    71. New Product Launch/Service Deployment
    72. Merger & Acquisitions
    73. Joint Ventures
    74. Major Players Financial Matrix
    75. Sales and Operating Income
    76. Major Players R&D Expenditure. 2023
    77. Company Profiles
    78. Siemens Healthineers
    79. Financial Overview
    80. Products Offered
    81. Key Developments
    82. SWOT Analysis
    83. Key Strategies
    84. F. HoffmannLa Roche
    85. Financial Overview
    86. Products Offered
    87. Key Developments
    88. SWOT Analysis
    89. Key Strategies
    90. Randox Laboratories
    91. Financial Overview
    92. Products Offered
    93. Key Developments
    94. SWOT Analysis
    95. Key Strategies
    96. Abbott Laboratories
    97. Financial Overview
    98. Products Offered
    99. Key Developments
    100. SWOT Analysis
    101. Key Strategies
    102. Werfen
    103. Financial Overview
    104. Products Offered
    105. Key Developments
    106. SWOT Analysis
    107. Key Strategies
    108. BioRad Laboratories
    109. Financial Overview
    110. Products Offered
    111. Key Developments
    112. SWOT Analysis
    113. Key Strategies
    114. Hematologic Technologies
    115. Financial Overview
    116. Products Offered
    117. Key Developments
    118. SWOT Analysis
    119. Key Strategies
    120. Ortho Clinical Diagnostics
    121. Financial Overview
    122. Products Offered
    123. Key Developments
    124. SWOT Analysis
    125. Key Strategies
    126. DiaSorin
    127. Financial Overview
    128. Products Offered
    129. Key Developments
    130. SWOT Analysis
    131. Key Strategies
    132. Thermo Fisher Scientific
    133. Financial Overview
    134. Products Offered
    135. Key Developments
    136. SWOT Analysis
    137. Key Strategies
    138. Progenika Biopharma
    139. Financial Overview
    140. Products Offered
    141. Key Developments
    142. SWOT Analysis
    143. Key Strategies
    144. Grifols
    145. Financial Overview
    146. Products Offered
    147. Key Developments
    148. SWOT Analysis
    149. Key Strategies
    150. Merck KGaA
    151. Financial Overview
    152. Products Offered
    153. Key Developments
    154. SWOT Analysis
    155. Key Strategies
    156. SeraCare Life Sciences
    157. Financial Overview
    158. Products Offered
    159. Key Developments
    160. SWOT Analysis
    161. Key Strategies
    162. Becton Dickinson
    163. Financial Overview
    164. Products Offered
    165. Key Developments
    166. SWOT Analysis
    167. Key Strategies
    168. References
    169. Related Reports
    170. India Blood Grouping Reagents Market SIZE ESTIMATES & FORECAST, BY PRODUCT, 2019-2035 (USD Billions)
    171. India Blood Grouping Reagents Market SIZE ESTIMATES & FORECAST, BY TECHNIQUE, 2019-2035 (USD Billions)
    172. India Blood Grouping Reagents Market SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD Billions)
    173. India Blood Grouping Reagents Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD Billions)
    174. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    175. ACQUISITION/PARTNERSHIP
    176. MARKET SYNOPSIS
    177. INDIA BLOOD GROUPING REAGENTS MARKET ANALYSIS BY PRODUCT
    178. INDIA BLOOD GROUPING REAGENTS MARKET ANALYSIS BY TECHNIQUE
    179. INDIA BLOOD GROUPING REAGENTS MARKET ANALYSIS BY TEST TYPE
    180. INDIA BLOOD GROUPING REAGENTS MARKET ANALYSIS BY END USER
    181. KEY BUYING CRITERIA OF BLOOD GROUPING REAGENTS MARKET
    182. RESEARCH PROCESS OF MRFR
    183. DRO ANALYSIS OF BLOOD GROUPING REAGENTS MARKET
    184. DRIVERS IMPACT ANALYSIS: BLOOD GROUPING REAGENTS MARKET
    185. RESTRAINTS IMPACT ANALYSIS: BLOOD GROUPING REAGENTS MARKET
    186. SUPPLY / VALUE CHAIN: BLOOD GROUPING REAGENTS MARKET
    187. BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2025 (% SHARE)
    188. BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2019 TO 2035 (USD Billions)
    189. BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2025 (% SHARE)
    190. BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2019 TO 2035 (USD Billions)
    191. BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2025 (% SHARE)
    192. BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2019 TO 2035 (USD Billions)
    193. BLOOD GROUPING REAGENTS MARKET, BY END USER, 2025 (% SHARE)
    194. BLOOD GROUPING REAGENTS MARKET, BY END USER, 2019 TO 2035 (USD Billions)
    195. BENCHMARKING OF MAJOR COMPETITORS

    India Blood Grouping Reagents Market Segmentation

    • Blood Grouping Reagents Market By Product (USD Million, 2019-2035)

      • Consumables
      • Instruments

     

    • Blood Grouping Reagents Market By Technique (USD Million, 2019-2035)

      • PCR-based and Microarray Techniques
      • Assay-Based Techniques
      • Massively Parallel Sequencing Techniques
      • Serology

     

    • Blood Grouping Reagents Market By Test Type (USD Million, 2019-2035)

      • Blood Group and Phenotypes
      • Antibody Screening
      • Crossmatching Tests
      • Antibody Identification
      • Coombs’s Test
      • Antigen Typing

     

    • Blood Grouping Reagents Market By End User (USD Million, 2019-2035)

      • Hospitals
      • Blood Banks
      • Clinical Laboratories
    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    No regional reports available for this market.

    No country-specific reports available for this market.

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027